Details for New Drug Application (NDA): 065505
The generic ingredient in CEFTRIAXONE is ceftriaxone sodium. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
Summary for 065505
| Tradename: | CEFTRIAXONE |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | ceftriaxone sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 065505
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Strength | EQ 250MG BASE/VIAL | ||||
| Approval Date: | Jul 31, 2008 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Jul 31, 2008 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Jul 31, 2008 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
